Modular Medical (NASDAQ:MODD – Get Free Report) and Guided Therapeutics (OTCMKTS:GTHP – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations and valuation.
Profitability
This table compares Modular Medical and Guided Therapeutics’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Modular Medical | N/A | -245.85% | -190.80% |
| Guided Therapeutics | N/A | N/A | -304.40% |
Analyst Recommendations
This is a summary of recent ratings and target prices for Modular Medical and Guided Therapeutics, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Modular Medical | 1 | 0 | 0 | 0 | 1.00 |
| Guided Therapeutics | 0 | 0 | 0 | 0 | 0.00 |
Valuation & Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Modular Medical | N/A | N/A | -$18.82 million | ($14.71) | -0.26 |
| Guided Therapeutics | $770,000.00 | 25.07 | -$3.20 million | ($0.04) | -5.00 |
Guided Therapeutics has higher revenue and earnings than Modular Medical. Guided Therapeutics is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
27.5% of Modular Medical shares are held by institutional investors. Comparatively, 9.7% of Guided Therapeutics shares are held by institutional investors. 7.1% of Modular Medical shares are held by insiders. Comparatively, 66.8% of Guided Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Risk & Volatility
Modular Medical has a beta of 0.24, indicating that its share price is 76% less volatile than the S&P 500. Comparatively, Guided Therapeutics has a beta of 0.79, indicating that its share price is 21% less volatile than the S&P 500.
Summary
Guided Therapeutics beats Modular Medical on 6 of the 10 factors compared between the two stocks.
About Modular Medical
Modular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.
About Guided Therapeutics
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.
Receive News & Ratings for Modular Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Modular Medical and related companies with MarketBeat.com's FREE daily email newsletter.
